CL2016000880A1 - Recubrimiento farmacéutico soluble en agua con estabilidad mejorada - Google Patents
Recubrimiento farmacéutico soluble en agua con estabilidad mejoradaInfo
- Publication number
- CL2016000880A1 CL2016000880A1 CL2016000880A CL2016000880A CL2016000880A1 CL 2016000880 A1 CL2016000880 A1 CL 2016000880A1 CL 2016000880 A CL2016000880 A CL 2016000880A CL 2016000880 A CL2016000880 A CL 2016000880A CL 2016000880 A1 CL2016000880 A1 CL 2016000880A1
- Authority
- CL
- Chile
- Prior art keywords
- coating
- water soluble
- improved stability
- soluble pharmaceutical
- molding
- Prior art date
Links
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title abstract 3
- 239000008016 pharmaceutical coating Substances 0.000 title 1
- 238000000034 method Methods 0.000 abstract 5
- 239000011248 coating agent Substances 0.000 abstract 4
- 238000000576 coating method Methods 0.000 abstract 4
- 238000001035 drying Methods 0.000 abstract 2
- 238000000465 moulding Methods 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000000654 additive Substances 0.000 abstract 1
- 230000001464 adherent effect Effects 0.000 abstract 1
- 238000004090 dissolution Methods 0.000 abstract 1
- 238000004806 packaging method and process Methods 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Manufacture Of Macromolecular Shaped Articles (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3221MU2013 IN2013MU03221A (https=) | 2013-10-14 | 2014-10-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2016000880A1 true CL2016000880A1 (es) | 2017-01-27 |
Family
ID=53274239
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2016000880A CL2016000880A1 (es) | 2013-10-14 | 2016-04-14 | Recubrimiento farmacéutico soluble en agua con estabilidad mejorada |
Country Status (8)
| Country | Link |
|---|---|
| BR (1) | BR112016008356B1 (https=) |
| CA (1) | CA2927334C (https=) |
| CL (1) | CL2016000880A1 (https=) |
| EA (1) | EA038558B1 (https=) |
| IN (1) | IN2013MU03221A (https=) |
| MY (1) | MY184297A (https=) |
| UA (1) | UA123893C2 (https=) |
| WO (1) | WO2015083181A2 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015107544A2 (en) * | 2013-12-17 | 2015-07-23 | Zim Laboratories Limited | Pharmaceutical microemulsion immobilized in a thin polymer matrix and methods of making them |
| EP3600265A1 (en) * | 2017-03-30 | 2020-02-05 | Intelgenx Corp. | Method of treatment and device for the improved bioavailability of leukotriene receptor antagonists |
| DE102017127452A1 (de) * | 2017-11-21 | 2019-05-23 | Lts Lohmann Therapie-Systeme Ag | Wasserlösliche Polymerklebschichten |
| FR3082851B1 (fr) * | 2018-06-25 | 2022-09-02 | Biomerieux Sa | Procede de detection et/ou d'identification d'au moins un microorganisme cible present sur une surface. |
| CN119015263B (zh) * | 2024-08-20 | 2025-07-11 | 云南白药集团无锡药业有限公司 | 一种云南白药口溶膜剂及其制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5947987B2 (ja) * | 1979-10-08 | 1984-11-22 | 富士写真フイルム株式会社 | 加筆・修正可能なマツトフイルム |
| US4664859A (en) * | 1983-12-02 | 1987-05-12 | Vcf Films Inc. Div. Of Pmc | Process for solvent casting a film |
| US5272191A (en) * | 1991-08-21 | 1993-12-21 | Fmc Corporation | Cold water soluble films and film forming compositions |
| US6966960B2 (en) * | 2003-05-07 | 2005-11-22 | Hewlett-Packard Development Company, L.P. | Fusible water-soluble films for fabricating three-dimensional objects |
| WO2005084636A2 (en) * | 2004-02-27 | 2005-09-15 | Ranbaxy Laboratories Limited | A process for the preparation of controlled-release pharmaceutical composition of metoprolol |
| KR100705210B1 (ko) * | 2004-09-23 | 2007-04-06 | 주식회사 한독약품 | 경구투여를 위한 당뇨병 치료용 약제학적 복합제제 |
| US20090162516A1 (en) * | 2007-12-21 | 2009-06-25 | Brown Solomon E | Edible, water-soluble film |
-
2014
- 2014-10-13 MY MYPI2016701359A patent/MY184297A/en unknown
- 2014-10-13 EA EA201690751A patent/EA038558B1/ru unknown
- 2014-10-13 WO PCT/IN2014/000652 patent/WO2015083181A2/en not_active Ceased
- 2014-10-13 IN IN3221MU2013 patent/IN2013MU03221A/en unknown
- 2014-10-13 UA UAA201605185A patent/UA123893C2/uk unknown
- 2014-10-13 CA CA2927334A patent/CA2927334C/en active Active
- 2014-10-13 BR BR112016008356-3A patent/BR112016008356B1/pt active IP Right Grant
-
2016
- 2016-04-14 CL CL2016000880A patent/CL2016000880A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IN2013MU03221A (https=) | 2015-07-03 |
| BR112016008356A2 (pt) | 2017-08-01 |
| WO2015083181A3 (en) | 2015-12-03 |
| BR112016008356B1 (pt) | 2022-12-13 |
| EA201690751A1 (ru) | 2016-08-31 |
| CA2927334A1 (en) | 2015-06-11 |
| WO2015083181A2 (en) | 2015-06-11 |
| EA038558B1 (ru) | 2021-09-14 |
| CA2927334C (en) | 2023-08-29 |
| MY184297A (en) | 2021-03-31 |
| UA123893C2 (uk) | 2021-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2016000880A1 (es) | Recubrimiento farmacéutico soluble en agua con estabilidad mejorada | |
| BR112018073703A2 (pt) | emplastro para pele ou ferida, composição farmacêutica e método para a liberação de uma substância ativa | |
| CL2016000882A1 (es) | Composiciones de arni contra el componente c5 del complemento y métodos para su uso (divisional de sol. n°2710-15). | |
| MX2015012302A (es) | Composiciones tópicas y métodos de tratamiento para trastornos de la piel. | |
| ECSP17078433A (es) | Composiciones de ácido obeticólico y métodos de uso | |
| DOP2017000162A (es) | Forma de dosificación que incluye una solución sólida de drogas amorfas | |
| MX391216B (es) | Composicion farmaceutica que comprende un vector adenoviral. | |
| BR112016006326A2 (pt) | formulação seca de uma vacina, uso de uma formulação seca, método para fabricação de uma formulação seca, e, vacina | |
| WO2014052640A8 (en) | Novel ampk agonist compositions and methods of use | |
| BR112015028278A2 (pt) | processo para a preparação de eritrócitos carregados com uma ou mais substâncias de interesse farmacêutico e eritrócitos assim obtidos | |
| MX384877B (es) | Composiciones de éster de colina de ácido lipoico y métodos de uso. | |
| IN2012DE00337A (https=) | ||
| CR20150432A (es) | Estra-1,3,5 (10), 16-tetraeno-3-carboxamidas para la inhibición de la 17b-hidroxiesteroide deshidrogenasa (akr1 c3) | |
| CL2014002986A1 (es) | Proceso para la preparacion de compuestos derivados de 2-(1-hidroxi-alquil)-cromen-4-ona opticamente puros y opcionalmente sustituidos; compuestos derivados de 2-(1-hidroxi-alquil)-cromen-4-ona; composicion farmaceutica que los comprende; y su uso para preparar compuestos inhibidores de pi3k. | |
| BR112016030274A2 (pt) | Métodos para fabricação de um material granular encapsulado e secagem de um material de revestimento, e, secador de leito fluidificado | |
| BR112015031417A8 (pt) | forma de dosagem farmacêutica, composição farmacêutica, métodos para tratamento de um paciente com necessidade de cisteamina e para preparo de uma forma de dosagem | |
| BR112015030431A2 (pt) | formulação de liberação modificada | |
| MX2016004856A (es) | Composiciones y metodos que se relacionan a un hidrogel de polimero oclusivo. | |
| BR112015018200A2 (pt) | composição mastigável para administração oral e processo para preparar a mesma | |
| MX373714B (es) | Composiciones de ketoprofeno de accion prolongada. | |
| CL2016000182A1 (es) | Composición farmacéutica anti-tuberculosis estable en una forma de un comprimido recubierto que comprende gránulos de isoniazid y gránulos de rifapentina y su proceso de preparación | |
| BR112016002165A2 (pt) | formulações compreendendo esfinganina | |
| BR112016011999A2 (pt) | Derivados de amida para agonista de gpr119 | |
| CY1121708T1 (el) | Ενωσεις ουριας ινδανυλιου που αναστελλουν την ρ38 map kιναση | |
| JP2019058545A5 (https=) |